Puma Biotech (PBYI) Q1 Earnings Beat, Nerlynx Sales Fall Y/Y
PUMA BIOTECHNOLOGY, INC. FORM 8-K/A - Shareholder.com
Puma Biotechnology
Puma Biotechnology: Alisertib Deal Alters My Strategy (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology: Alisertib Deal Alters My Strategy (NASDAQ:PBYI) | Seeking Alpha
PUMA BIOTECHNOLOGY, INC. FORM 10-K - Biotech Due Diligence
Here's Why Puma Biotechnology, Inc. (PBYI) is Down on Tuesday
Puma Biotech punts near $300 million on Takeda discard
ADAPTING
Puma Biotechnology, Inc.
Puma Biotechnology: Finding Bullish Indications At The End Of 2019 (NASDAQ:PBYI) | Seeking Alpha
Product Pipeline
PUMA BIOTECHNOLOGY, INC.
printmgr file
A New Drug on the Horizon for HER2 Breast Cancer Patients | Avise Analytics
Puma Biotechnology: Who Are They? What Happened? And, Where Are They Going? (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology: Alisertib Deal Alters My Strategy (NASDAQ:PBYI) | Seeking Alpha
Neratinib Chapter
Why Puma Biotechnology, Inc. Stock Crashed 37% in March | Fox Business
Knight Therapeutics licences cancer drug from Puma Biotechnology
Puma Biotech (PBYI) Up More Than 95% in 3 Months: Here's Why
Jon Mead - Vice President of FP&A - Puma Biotechnology, Inc. | LinkedIn
Daiichi Sankyo and Puma Biotechnology Announce Research Collaboration with Major Cancer Center in HER2-Mutated Cancer | Business Wire
Why Puma Biotechnology, Inc. Stock Crashed 37% in March | The Motley Fool
Puma Biotechnology Careers | Wellfound (formerly AngelList Talent)
Why Puma Biotechnology's Shares Jumped 20% on Monday | The Motley Fool
